Mechanism of in vitro sensitization of temozolomide to MGMT+ glioma cell line by FM19G11
Objective To investigate whether FM19G11 affects the sensitivity of human-derived malignant glioma cell line T98G to temozolomide (TMZ) and underlying molecular mechanisms. Methods T98G cells were treated with 0, 0.5, 1 and 2 μmol/L of FM19G11 and TMZ separately and jointly. The CCK-8 assay and ce...
Main Author: | FANG Huang-yi, YOU Chao-guo, PANG Chen, ZHANG Zhong-ding, ZHANG Zhe, KUANG Tong-shuai, SHENG Han-song |
---|---|
Format: | Article |
Language: | zho |
Published: |
Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.
2021-04-01
|
Series: | Jichu yixue yu linchuang |
Subjects: | |
Online Access: | http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/a200139.pdf |
Similar Items
-
Quantitative Analysis of the <i>MGMT</i> Methylation Status of Glioblastomas in Light of the 2021 WHO Classification
by: Levin Häni, et al.
Published: (2022-06-01) -
Experimental study of selective MGMT peptides mimicking TMZ drug resistance in glioma
by: Yue Wu, et al.
Published: (2022-12-01) -
Prognostic genetic markers in malignant gliomas
by: Ralf Ketter, et al.
Published: (2010-12-01) -
Retrospective study on MGMT methylation status and its clinical significance in gliomas
by: JIANG Lin, LIU Qiying, JIA Liqing, ZHANG Jing, CHANG Heng, XUE Tian, REN Min, BAI Qianming, ZHU Xiaoli, ZHOU Xiaoyan
Published: (2023-08-01) -
Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin
by: Shao-Wei Feng, et al.
Published: (2022-07-01)